te Loo D Maroeska W M, Kamps Willem A, van der Does-van den Berg Anna, van Wering Elisabeth R, de Graaf Siebold S N
University Medical Center St Radboud, Nijmegen, The Netherlands.
J Clin Oncol. 2006 May 20;24(15):2332-6. doi: 10.1200/JCO.2005.03.9727.
To determine the significance of blasts in the CSF without pleiocytosis and a traumatic lumbar puncture in children with acute lymphoblastic leukemia (ALL).
We retrospectively studied a cohort of 526 patients treated in accordance with the virtually identical Dutch protocols ALL-7 and ALL-8. Patients were classified into five groups: CNS1, no blasts in the CSF cytospin; CNS2, blasts present in the cytospin, but leukocytes less than 5/microL; CNS3, blasts present and leukocytes more than 5/microL. Patients with a traumatic lumbar puncture (TLP; > 10 erythrocytes/mL) were classified as TLP+ (blasts present in the cytospin) or TLP- (no blasts).
Median duration of follow-up was 13.2 years (range, 6.9 to 15.5 years). Event-free survival (EFS) was 72.6% (SE, 2.5%) for CNS1 patients (n = 304), 70.3% (SE, 4.7%) for CNS2 patients (n = 111), and 66.7% (SE, 19%) for CNS3 patients (n = 10; no significant difference in EFS between the groups). EFS was 58% (SE, 7.6%) for TLP+ patients (n = 62) and 82% (SE, 5.2%) for TLP- patients (n = 39; P < .01). Cox regression analysis identified TLP+ status as an independent prognostic factor (risk ratio, 3.5; 95% CI, 1.4 to 8.8; P = .007). Cumulative incidence of CNS relapses was 0.05 and 0.07 in CNS1 and CNS2 patients, respectively (not statistically significant).
In our experience, the presence of a low number of blasts in the CSF without pleiocytosis has no prognostic significance. In contrast, a traumatic lumbar puncture with blasts in the CSF specimen is associated with an inferior outcome.
确定急性淋巴细胞白血病(ALL)患儿脑脊液中存在原始细胞但无细胞增多症以及创伤性腰椎穿刺的意义。
我们回顾性研究了一组按照几乎相同的荷兰ALL - 7和ALL - 8方案治疗的526例患者。患者分为五组:CNS1,脑脊液细胞离心涂片无原始细胞;CNS2,细胞离心涂片有原始细胞,但白细胞少于5/μL;CNS3,有原始细胞且白细胞多于5/μL。创伤性腰椎穿刺(TLP;红细胞>10/mL)的患者分为TLP +(细胞离心涂片有原始细胞)或TLP -(无原始细胞)。
中位随访时间为13.2年(范围6.9至15.5年)。CNS1组患者(n = 304)的无事件生存率(EFS)为72.6%(SE,2.5%),CNS2组患者(n = 111)为70.3%(SE,4.7%),CNS3组患者(n = 10)为66.7%(SE,19%)(各组间EFS无显著差异)。TLP +组患者(n = 62)的EFS为58%(SE,7.6%),TLP -组患者(n = 39)为82%(SE,5.2%)(P <.01)。Cox回归分析确定TLP +状态为独立预后因素(风险比,3.5;95%CI,1.4至8.8;P =.007)。CNS1和CNS2患者的CNS复发累积发生率分别为0.05和0.07(无统计学意义)。
根据我们的经验,脑脊液中存在少量原始细胞但无细胞增多症无预后意义。相反,脑脊液标本中有原始细胞的创伤性腰椎穿刺与较差的预后相关。